Andrew Kesselman, MD
Interventional Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kesselman’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A141867 · Current
Licensed to practise in California · since 2016 · expires 2027-12-31 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$75,688
Medicare paid this office $75,688 for 237 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of growth of liver through skin using radiofrequency | 15 | $10,129 | $633 |
| Balloon dilation of vein with review by radiologist, initial vein | 14 | $3,465 | $204 |
| Ct guidance for tissue removal | 20 | $3,356 | $160 |
| New patient visit (45+ min) | 17 | $2,706 | $159 |
| Return visit (30+ min) | 19 | $2,508 | $119 |
See all 14 services
| Destruction of growth of liver through skin using radiofrequency | 15 | $10,129 | $633 |
| Balloon dilation of vein with review by radiologist, initial vein | 14 | $3,465 | $204 |
| Ct guidance for tissue removal | 20 | $3,356 | $160 |
| New patient visit (45+ min) | 17 | $2,706 | $159 |
| Return visit (30+ min) | 19 | $2,508 | $119 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 13 | $2,214 | $158 |
| Long return visit (40+ min) | 11 | $2,065 | $172 |
| Insertion of tube into vein, second order branch | 13 | $1,333 | $78 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 12 | $1,135 | $41 |
| Needle biopsy of liver through skin | 14 | $971 | $69 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 66 | $745 | $10 |
| Ct scan of chest without contrast | 17 | $723 | $43 |
| Ultrasonic guidance for blood vessel access | 36 | $550 | $12 |
| Ultrasonic guidance for needle placement | 17 | $453 | $27 |
Who their Medicare patients are
237 Original Medicare patients in 2024. Average age 73 · Under 65 12% · 85 and older 11% · Women 53% · Also on Medicaid 28% · Health risk score 2.43. Above the middle of the specialty; the typical interventional radiology clinician is at 2.27.
Conditions among them: High blood pressure 75% · Diabetes 38% · Coronary heart disease 38% · Chronic kidney disease 36% · Cancer 35% · Atrial fibrillation 25% · Heart failure 24% · Depression 22% · COPD 20% · Dementia 10% · Stroke 10%.
The office billed $2,047,512, Medicare allowed $95,585 and paid $75,688; for 724 services of 138 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 237 | 724 | 73 | 2.43 | $2,047,512 | $75,688 |
| 2023 | 256 | 818 | 72 | 2.61 | $1,613,198 | $73,290 |
| 2022 | 240 | 810 | 73 | 2.48 | $957,330 | $44,745 |
| 2021 | 304 | 2,073 | 73 | 3.51 | $1,474,317 | $70,466 |
| 2020 | 219 | 919 | 72 | 3.18 | $1,078,438 | $52,636 |
| 2019 | 223 | 2,142 | 72 | 3.71 | $1,277,469 | $64,436 |
| 2018 | 1,526 | 3,022 | 76 | 2.03 | $1,093,865 | $101,206 |
| 2017 | 403 | 699 | 71 | 2.29 | $413,259 | $31,889 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Review by radiologist of abdominal artery image | 12 | $2,646 | $85 |
| New patient visit (45+ min) | 20 | $2,209 | $110 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 12 | $1,974 | $152 |
| Long return visit (40+ min) | 13 | $1,729 | $133 |
| Review by radiologist of additional artery image | 13 | $1,546 | $42 |
| Return visit (30+ min) | 14 | $1,445 | $90 |
| Needle biopsy of liver through skin | 16 | $1,210 | $76 |
| Review by radiologist of ct guidance for needle placement | 17 | $1,093 | $64 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 11 | $1,014 | $42 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 12 | $974 | $75 |
| Exchange of abdominal cavity drainage tube using imaging guidance | 11 | $816 | $58 |
| Short return visit (20+ min) | 12 | $793 | $57 |
| Ultrasonic guidance for needle placement | 23 | $610 | $27 |
| Ultrasonic guidance for blood vessel access | 32 | $487 | $12 |
| Review by radiologist of image for replacement of stomach or large bowel tube | 11 | $482 | $34 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 80 | $408 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 20 | $231 | $11 |
| X-ray of chest, 2 views | 11 | $105 | $10 |
2022: 7 services
| Review by radiologist of ct guidance for needle placement | 12 | $777 | $65 |
| X-ray of chest, 1 view | 61 | $518 | $8 |
| Ultrasonic guidance for needle placement | 13 | $335 | $26 |
| Ultrasonic guidance for blood vessel access | 22 | $310 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $279 | $12 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 48 | $228 | $5 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 11 | $188 | $17 |
2021: 14 services
| Drainage of fluid collection of abdominal cavity by tube using imaging guidance | 14 | $2,865 | $179 |
| Short return visit (20+ min) | 33 | $2,555 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,537 | $67 |
| Review by radiologist of ct guidance for needle placement | 20 | $1,410 | $67 |
| Drainage of fluid from abdominal cavity using imaging guidance | 12 | $1,165 | $83 |
| Replacement of kidney drainage tube using imaging guidance with review by radiologist | 11 | $1,127 | $94 |
| Needle biopsy of liver through skin | 11 | $972 | $75 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 67 | $834 | $12 |
| Ultrasonic guidance for needle placement | 16 | $491 | $29 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 21 | $373 | $18 |
| X-ray of chest, 1 view | 39 | $316 | $8 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 11 | $267 | $17 |
| Ultrasonic guidance for blood vessel access | 18 | $231 | $13 |
| X-ray of chest, 2 views | 11 | $91 | $8 |
2020: 11 services
| Insertion of tunneled central venous tube for infusion (5 years or older) | 12 | $3,322 | $256 |
| Review by radiologist of ct guidance for needle placement | 21 | $1,371 | $65 |
| Drainage of fluid from abdominal cavity using imaging guidance | 12 | $1,291 | $92 |
| Return visit (30+ min) | 14 | $1,104 | $74 |
| Short return visit (20+ min) | 18 | $962 | $38 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 13 | $651 | $30 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | $649 | $11 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 24 | $437 | $17 |
| Ultrasonic guidance for needle placement | 12 | $350 | $29 |
| Ultrasonic guidance for blood vessel access | 21 | $296 | $13 |
| X-ray of chest, 1 view | 17 | $152 | $8 |
2019: 9 services
| Review by radiologist of ct guidance for needle placement | 50 | $3,223 | $64 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 11 | $2,614 | $238 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 23 | $1,836 | $76 |
| Drainage of fluid from abdominal cavity using imaging guidance | 11 | $1,332 | $95 |
| Return visit (30+ min) | 11 | $1,257 | $66 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 72 | $837 | $11 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 26 | $467 | $17 |
| Ultrasonic guidance for needle placement | 12 | $368 | $28 |
| Ultrasonic guidance for blood vessel access | 26 | $334 | $13 |
2018: 47 services
| Ct scan of abdomen and pelvis with contrast | 61 | $4,844 | $76 |
| X-ray of chest, 1 view | 304 | $3,340 | $8 |
| Ct scan head or brain without contrast | 93 | $3,292 | $35 |
| Ct scan of blood vessels of chest with contrast | 35 | $2,790 | $80 |
| Ct scan of abdomen and pelvis without contrast | 36 | $2,649 | $74 |
| Ct scan of chest without contrast | 49 | $2,595 | $52 |
| Drainage of fluid collection of abdominal cavity by tube using imaging guidance | 12 | $2,110 | $176 |
| X-ray of chest, 2 views | 214 | $2,080 | $9 |
| Review by radiologist of ct guidance for needle placement | 36 | $1,805 | $49 |
| Mri scan of brain without contrast | 28 | $1,740 | $62 |
| Ct scan of abdomen and pelvis with contrast | 19 | $1,555 | $82 |
| Drainage of fluid from abdominal cavity using imaging guidance | 13 | $1,481 | $87 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 18 | $1,426 | $75 |
| Mri scan of lower spinal canal without contrast | 21 | $1,391 | $66 |
| Complete ultrasound scan behind abdominal cavity | 33 | $1,085 | $33 |
| Ct scan of abdomen and pelvis before and after contrast | 12 | $998 | $83 |
| Ct scan of upper spine without contrast | 19 | $870 | $46 |
| Ct scan of chest with contrast | 16 | $860 | $54 |
| Mri scan of lower spinal canal without contrast | 13 | $852 | $66 |
| Ultrasound of both sides of head and neck blood flow | 26 | $845 | $32 |
| Ct scan of chest without contrast | 16 | $784 | $49 |
| Needle biopsy of liver through skin | 11 | $781 | $71 |
| X-ray of chest, 2 views | 77 | $753 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 64 | $740 | $11 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 35 | $660 | $19 |
| Complete ultrasound scan of abdomen | 18 | $653 | $36 |
| Ultrasonic guidance for needle placement | 23 | $648 | $28 |
| Ultrasound of both sides of head and neck blood flow | 18 | $634 | $35 |
| Ultrasound scan of head and neck soft tissue | 26 | $620 | $24 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 29 | $514 | $17 |
| 3d radiographic procedure with computerized image postprocessing | 13 | $464 | $36 |
| X-ray of abdomen, 1 view | 40 | $451 | $8 |
| Limited ultrasound scan of abdomen | 18 | $445 | $23 |
| Ultrasonic guidance for blood vessel access | 32 | $409 | $13 |
| Ultrasound scan of head and neck soft tissue | 18 | $399 | $22 |
| Complete ultrasound scan of pelvis | 13 | $367 | $28 |
| X-ray of hip, 2-3 views | 32 | $335 | $10 |
| Complete ultrasound scan behind abdominal cavity | 11 | $330 | $30 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 11 | $298 | $27 |
| X-ray of lower and sacral spine, 2-3 views | 27 | $254 | $9 |
| X-ray of knee, 3 views | 28 | $214 | $7 |
| X-ray of shoulder, minimum of 2 views | 19 | $159 | $8 |
| X-ray of chest, 1 view | 19 | $156 | $8 |
| X-ray of knee, 1-2 views | 18 | $144 | $8 |
| X-ray of pelvis, 1-2 views | 16 | $126 | $8 |
| X-ray of foot, minimum of 3 views | 12 | $75 | $6 |
| X-ray of wrist, minimum of 3 views | 11 | $47 | $4 |
2017: 6 services
| Review by radiologist of ct guidance for needle placement | 31 | $1,646 | $51 |
| X-ray of chest, 2 views, front and side | 144 | $1,620 | $10 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 15 | $1,216 | $76 |
| X-ray of chest, 1 view, front | 107 | $935 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 78 | $883 | $11 |
| X-ray of chest, 2 views, front and side | 51 | $511 | $10 |
Medicaid work
$2,197 in 2022
Medicaid paid $2,197 for 70 billed services this clinician did in 2022, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 56 | $2,140 |
| Radiologic examination, chest; single view | 14 | $58 |
| 2022 | 70 | 2 | 20 | $2,197 |
| 2021 | 12 | 1 | 12 | $149 |
| 2018 | 273 | 3 | 31 | $2,647 |
See the largest Medicaid services in earlier years
2021
| Radiologic examination, chest; 2 views | 12 | $149 |
2018
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 39 | $1,841 |
| Radiologic examination, chest; single view | 161 | $553 |
| Radiologic examination, chest; 2 views | 73 | $253 |
Drugs they prescribed that Part D paid
$9,972
Pharmacies billed $9,972 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
26 generic and 13 brand-name prescriptions · $9,972 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 13 | $9,872 | $759 |
Year by year
| 2024 | 39 | 22 | None | 33% | $9,972 |
| 2023 | 33 | 17 | None | 33% | $12,229 |
| 2020 | 29 | None | None | 86% | $14,757 |
| 2019 | 13 | None | 0% (0) | 100% | $8,240 |
| 2018 | 20 | 14 | None | None | $983 |
| 2017 | 77 | 32 | 26% (20) | None | $3,242 |
| 2016 | 31 | 16 | 42% (13) | 0% | $248 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Eliquis | 25 | $14,741 | $590 |
2017: 4 drugs
| Ondansetron | 18 | $209 | $12 |
| Pantoprazole | 18 | $131 | $7 |
| Oxycodone | 17 | $110 | $6 |
| Gabapentin | 12 | $37 | $3 |
2016: 1 drug
| Oxycodone | 12 | $82 | $7 |
Money from drug and device companies
$7,216 in 2025
| 2025 | 9 | 22 | $5,700 | $7,216 |
| 2024 | 9 | 14 | None | $911 |
| 2023 | 7 | 13 | None | $1,721 |
| 2022 | 2 | 4 | None | $193 |
| 2021 | 2 | 2 | None | $142 |
| 2020 | 4 | 6 | $2,500 | $2,668 |
| 2019 | 6 | 11 | $900 | $1,551 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Cook | Cook | $3,000 | 1 payment
|
| Flowphysix | Flowrunner | $2,700 | 1 payment
|
| W. L. Gore & Associates | Gore Viabahn Endoprosthesis | $651 | 10 payments
|
| Bard Peripheral Vascular | Denali Vena Cava Filter | $237 | 2 payments
|
| Balt USA | Prestige Coil System | $181 | 1 payment
|
| Ge Healthcare | None | $159 | 1 payment
|
See all 22 published payments
| Medtronic | Meals · 2025-09-24 | Emprint | $128 |
| Ge Healthcare | Meals · 2025-09-23 | None | $159 |
| Bard Peripheral Vascular | Meals · 2025-09-21 | Denali Vena Cava Filter | $166 |
| Medtronic | Meals · 2025-08-03 | Emprint | $25 |
| Flowphysix | Consulting · 2025-07-28 | Flowrunner | $2,700 |
| W. L. Gore & Associates | Travel · 2025-06-26 | Gore Viabahn Endoprosthesis | $34 |
| W. L. Gore & Associates | Travel · 2025-06-26 | Gore Viabahn Endoprosthesis | $7 |
| W. L. Gore & Associates | Meals · 2025-06-25 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion | $3 |
| W. L. Gore & Associates | Meals · 2025-06-25 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion | $32 |
| W. L. Gore & Associates | Meals · 2025-06-25 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion | $9 |
| W. L. Gore & Associates | Travel · 2025-06-25 | Gore Viabahn Endoprosthesis | $92 |
| W. L. Gore & Associates | Travel · 2025-06-25 | Gore Viabahn Endoprosthesis | $240 |
| Boston Scientific | Meals · 2025-05-28 | Obsidio | $17 |
| W. L. Gore & Associates | Travel · 2025-05-21 | Gore Viabahn Vbx Balloon Expandable Endo | $99 |
| W. L. Gore & Associates | Travel · 2025-05-21 | Gore Viabahn Vbx Balloon Expandable Endo | $102 |
| Cook | Consulting · 2025-04-22 | Cook | $3,000 |
| Bard Peripheral Vascular | Meals · 2025-04-09 | Venovo | $72 |
| Boston Scientific | Meals · 2025-04-02 | Embold Fibered | $77 |
| W. L. Gore & Associates | Meals · 2025-04-01 | Product in Development | $32 |
| Balt USA | Meals · 2025-04-01 | Prestige Coil System | $181 |
| Boston Scientific | Meals · 2025-03-29 | Embold Fibered | $23 |
| Okami Medical | Meals · 2025-02-07 | Lobo | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $911
| Penumbra | Indigo System | $241 | 2 payments
|
| Bard Peripheral Vascular | Lutonix Drug Coated Balloon | $140 | 1 payment
|
| Medtronic | Emprint | $136 | 3 payments
|
| Inari Medical | Flowtriever Catheter, S | $113 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $104 | 1 payment
|
| Boston Scientific | Therasphere Y90 Glass Microspheres 10 Gbq | $97 | 3 payments
|
| Ethicon US | Neuwave | $33 | 1 payment
|
| Ge Healthcare | Allia | $31 | 1 payment
|
| Abbott Laboratories | Jeti All in One Non-Sterile Kit | $18 | 1 payment
|
2023: $1,721
| GE HealthCare | None | $1,188 | 3 payments
|
| Inari Medical | Flowtriever Catheter, S | $311 | 4 payments
|
| Bard Peripheral Vascular | Venovo | $140 | 2 payments
|
| Abbott Laboratories | Jeti | $30 | 1 payment
|
| AngioDynamics | Alphavac | $19 | 1 payment
|
| Terumo Medical | Azur Cx Detachable | $18 | 1 payment
|
| Boston Scientific | Embold Fibered | $16 | 1 payment
|
2022: $193
| Inari Medical | Flowtriever Catheter, S | $185 | 3 payments
|
| Sirtex Medical | Sir-Spheres Microspheres | $8 | 1 payment
|
2021: $142
| Terumo Medical | Hydropearl | $125 | 1 payment
|
| Argon Medical Devices | Tips | $17 | 1 payment
|
2020: $2,668
| Dova Pharmaceuticals | Doptelet | $2,500 | 1 payment
|
| Surefire Medical | Precision Infusion System | $115 | 2 payments
|
| Argon Medical Devices | Biopince Ultra | $39 | 2 payments
|
| Medtronic USA | Kyphon Balloon Kyphoplasty | $14 | 1 payment
|
2019: $1,551
| Argon Medical Devices | Cleaner | $900 | 2 payments
|
| Abbott Laboratories | Perclose Proglide Suture Mediated Closure System | $183 | 1 payment
|
| Penumbra | Penumbra Ruby Coil | $172 | 2 payments
|
| Boston Scientific | Epic Vascular | $164 | 2 payments
|
| Bard Peripheral Vascular | Venovo | $94 | 2 payments
|
| Inari Medical | Flowtriever | $38 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Boston Scientific Corporation · Virtus · 2021 | Their institution | $600 |
| Boston Scientific Corporation · Virtus · 2019 | Their institution | $200 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033401849
- Licence
- CA A141867, NY 282294California A141867: Current · expires 2027-12-31
- Trained
- New York Medical College, 2011
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085R0204X (2085R0204X); Diagnostic radiology (2085R0202X); General practice (208D00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-05-11
- NPI last updated
- 2024-04-09
- NPI record certified
- 2024-04-09
This is when the NPI record was last certified, not a medical board exam.